Published in J Drugs Dermatol on February 13, 2004
Does the pharmaceutical industry influence guidelines?: two examples from Germany. Dtsch Arztebl Int (2013) 3.78
The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study. Health Qual Life Outcomes (2006) 1.31
The long-term efficacy and safety of new biological therapies for psoriasis. Arch Dermatol Res (2006) 0.90
Impact of efalizumab on patient-reported outcomes in high-need psoriasis patients: results of the international, randomized, placebo-controlled Phase III Clinical Experience Acquired with Raptiva (CLEAR) trial [NCT00256139]. BMC Dermatol (2005) 0.88
Biologics in the management of psoriasis. Clin Cosmet Investig Dermatol (2009) 0.75
Efalizumab-induced severe thrombocytopenia can be resolved. Biologics (2008) 0.75
Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol (2004) 8.70
A randomized trial of epidural glucocorticoid injections for spinal stenosis. N Engl J Med (2014) 5.01
Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J Allergy Clin Immunol (2006) 4.80
Health-related quality of life associated with chronic conditions in eight countries: results from the International Quality of Life Assessment (IQOLA) Project. Qual Life Res (2004) 4.33
Constructing experimental designs for discrete-choice experiments: report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force. Value Health (2013) 2.82
Efalizumab for patients with moderate to severe plaque psoriasis: a randomized controlled trial. JAMA (2003) 2.50
The minimally important difference of the Asthma Control Test. J Allergy Clin Immunol (2009) 2.34
Applications of computerized adaptive testing (CAT) to the assessment of headache impact. Qual Life Res (2003) 2.33
A 52-week trial comparing briakinumab with methotrexate in patients with psoriasis. N Engl J Med (2011) 2.32
Calibration of an item pool for assessing the burden of headaches: an application of item response theory to the headache impact test (HIT). Qual Life Res (2003) 2.14
Better assessment of physical function: item improvement is neglected but essential. Arthritis Res Ther (2009) 2.04
Usefulness of the SF-8 Health Survey for comparing the impact of migraine and other conditions. Qual Life Res (2003) 1.66
Using item response theory to calibrate the Headache Impact Test (HIT) to the metric of traditional headache scales. Qual Life Res (2003) 1.60
Longitudinal analysis of sexual function reported by men in the Prostate Cancer Prevention Trial. J Natl Cancer Inst (2007) 1.52
Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics. J Am Acad Dermatol (2013) 1.50
Score comparability of short forms and computerized adaptive testing: Simulation study with the activity measure for post-acute care. Arch Phys Med Rehabil (2004) 1.48
Economic outcome of cardiac CT-based evaluation and standard of care for suspected acute coronary syndrome in the emergency department: a decision analytic model. Acad Radiol (2011) 1.45
Predicting declines in physical function in persons with multiple chronic medical conditions: what we can learn from the medical problem list. Health Qual Life Outcomes (2004) 1.44
Good research practices for measuring drug costs in cost-effectiveness analyses: a societal perspective: the ISPOR Drug Cost Task Force report--Part II. Value Health (2009) 1.43
Improving the response choices on the veterans SF-36 health survey role functioning scales: results from the Veterans Health Study. J Ambul Care Manage (2004) 1.42
Health-related quality of life in early rheumatoid arthritis: impact of disease and treatment response. Am J Manag Care (2002) 1.37
Extended efalizumab therapy improves chronic plaque psoriasis: results from a randomized phase III trial. J Am Acad Dermatol (2005) 1.34
Method of administration of PROMIS scales did not significantly impact score level, reliability, or validity. J Clin Epidemiol (2014) 1.34
Predicting risk of airflow obstruction in primary care: Validation of the lung function questionnaire (LFQ). Respir Med (2010) 1.33
A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis. J Am Acad Dermatol (2002) 1.33
Psychometric evaluation of the SF-36 health survey in Medicare managed care. Health Care Financ Rev (2004) 1.30
Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease: meta-analysis of six randomized controlled trials. J Am Geriatr Soc (2002) 1.26
Validity of the Asthma Control Test completed at home. Am J Manag Care (2007) 1.25
Anti-IL-17 receptor antibody AMG 827 leads to rapid clinical response in subjects with moderate to severe psoriasis: results from a phase I, randomized, placebo-controlled trial. J Invest Dermatol (2012) 1.23
Burden of restless legs syndrome on health-related quality of life. Qual Life Res (2007) 1.21
Development and initial psychometric evaluation of the participation measure for post-acute care (PM-PAC). Am J Phys Med Rehabil (2007) 1.21
Using the SF-12 health status measure to improve predictions of medical expenditures. Med Care (2006) 1.20
Validity and reliability of patient reported outcomes used in psoriasis: results from two randomized clinical trials. Health Qual Life Outcomes (2003) 1.17
Difference in method of administration did not significantly impact item response: an IRT-based analysis from the Patient-Reported Outcomes Measurement Information System (PROMIS) initiative. Qual Life Res (2013) 1.17
The ACTIVE cognitive training trial and predicted medical expenditures. BMC Health Serv Res (2009) 1.14
Assessing a structured, quantitative health outcomes approach to drug risk-benefit analysis. Health Aff (Millwood) (2007) 1.12
Use of patient-reported sleep measures in clinical trials of pain treatment: a literature review and synthesis of current sleep measures and a conceptual model of sleep disturbance in pain. Clin Ther (2007) 1.12
Reliability and predictive validity of the Asthma Control Test administered by telephone calls using speech recognition technology. J Allergy Clin Immunol (2006) 1.11
Validation of the asthma impact survey, a brief asthma-specific quality of life tool. Qual Life Res (2006) 1.09
Validation testing of a three-component model of Short Form-36 scores. J Clin Epidemiol (2011) 1.08
Test for respiratory and asthma control in kids (TRACK): a caregiver-completed questionnaire for preschool-aged children. J Allergy Clin Immunol (2009) 1.08
Psychometric evaluation and tests of validity of the Medical Outcomes Study 12-item Sleep Scale (MOS sleep). Sleep Med (2008) 1.07
Short-form activity measure for post-acute care. Arch Phys Med Rehabil (2004) 1.07
Development of the Lung Function Questionnaire (LFQ) to identify airflow obstruction. Int J Chron Obstruct Pulmon Dis (2010) 1.07
Validation of the Headache Impact Test (HIT-6™) across episodic and chronic migraine. Cephalalgia (2010) 1.06
A phase III, randomized, controlled trial of the fully human IL-12/23 mAb briakinumab in moderate-to-severe psoriasis. J Invest Dermatol (2011) 1.06
The relationship between asthma-specific quality of life and asthma control. J Asthma (2007) 1.05
Item response theory methods can improve the measurement of physical function by combining the modified health assessment questionnaire and the SF-36 physical function scale. Qual Life Res (2007) 1.02
Efficacy of the HPV-16/18 AS04-adjuvanted vaccine against low-risk HPV types (PATRICIA randomized trial): an unexpected observation. J Infect Dis (2013) 1.00
Patient-reported functional health and well-being outcomes with drug therapy: a systematic review of randomized trials using the SF-36 health survey. Med Care (2014) 0.99
Improvements in patient-reported outcomes with apremilast, an oral phosphodiesterase 4 inhibitor, in the treatment of moderate to severe psoriasis: results from a phase IIb randomized, controlled study. Health Qual Life Outcomes (2013) 0.98
Psychometric validation of the rhinitis control assessment test: a brief patient-completed instrument for evaluating rhinitis symptom control. Ann Allergy Asthma Immunol (2010) 0.97
The potential synergy between cognitive models and modern psychometric models. Qual Life Res (2003) 0.96
Long-term safety experience of ustekinumab in patients with moderate to severe psoriasis (Part II of II): results from analyses of infections and malignancy from pooled phase II and III clinical trials. J Am Acad Dermatol (2011) 0.95
Treatment of rheumatoid arthritis patients with abatacept and methotrexate significantly improved health-related quality of life. J Rheumatol (2006) 0.95
The feasibility of applying item response theory to measures of migraine impact: a re-analysis of three clinical studies. Qual Life Res (2003) 0.94
Health-related quality of life of heart failure and coronary artery disease patients improved during participation in disease management programs: a longitudinal observational study. Dis Manag (2007) 0.94
Impact of weight on the efficacy and safety of ustekinumab in patients with moderate to severe psoriasis: rationale for dosing recommendations. J Am Acad Dermatol (2010) 0.94
Study protocol: the Back Pain Outcomes using Longitudinal Data (BOLD) registry. BMC Musculoskelet Disord (2012) 0.94
Safety and tolerability of 1% pimecrolimus cream among infants: experience with 1133 patients treated for up to 2 years. Pediatrics (2005) 0.93
Test for Respiratory and Asthma Control in Kids (TRACK): clinically meaningful changes in score. J Allergy Clin Immunol (2011) 0.92
Predictors of asthma control in a random sample of asthmatic patients. J Asthma (2007) 0.91
A Canadian online survey to evaluate awareness and treatment satisfaction in individuals with moderate to severe plaque psoriasis. Int J Dermatol (2010) 0.91
Challenges in diagnosing latent tuberculosis infection in patients treated with tumor necrosis factor antagonists. J Rheumatol (2011) 0.91
A psychometric comparison of three patient-based measures of asthma control. Curr Med Res Opin (2007) 0.90
An evaluation of a patient-reported outcomes found computerized adaptive testing was efficient in assessing osteoarthritis impact. J Clin Epidemiol (2006) 0.90
Computerized adaptive testing--ready for ambulatory monitoring? Psychosom Med (2012) 0.90
Development and validation of the Lupus Impact Tracker: a patient-completed tool for clinical practice to assess and monitor the impact of systemic lupus erythematosus. Arthritis Care Res (Hoboken) (2014) 0.89
Evaluating the efficacy of sequential biologic therapies for rheumatoid arthritis patients with an inadequate response to tumor necrosis factor-α inhibitors. Arthritis Res Ther (2011) 0.88
Study protocol- Lumbar Epidural steroid injections for Spinal Stenosis (LESS): a double-blind randomized controlled trial of epidural steroid injections for lumbar spinal stenosis among older adults. BMC Musculoskelet Disord (2012) 0.88
Validating Migraine-Specific Quality of Life Questionnaire v2.1 in episodic and chronic migraine. Headache (2011) 0.88
Energy, fatigue, or both? A bifactor modeling approach to the conceptualization and measurement of vitality. Qual Life Res (2014) 0.88
Using the bootstrap to establish statistical significance for relative validity comparisons among patient-reported outcome measures. Health Qual Life Outcomes (2013) 0.87
Integrated safety analysis: short- and long-term safety profiles of etanercept in patients with psoriasis. J Am Acad Dermatol (2011) 0.87
Development and preliminary testing of a computerized adaptive assessment of chronic pain. J Pain (2009) 0.86
Systematic review of comparative effectiveness data for oncology orphan drugs. Am J Manag Care (2012) 0.86
Managing cardiovascular risk in patients with chronic inflammatory diseases. Clin Rheumatol (2012) 0.84
Reliability, validity, and responsiveness of the Rhinitis Control Assessment Test in patients with rhinitis. J Allergy Clin Immunol (2012) 0.84
Longitudinal validation of the Test for Respiratory and Asthma Control in Kids in pediatric practices. Pediatrics (2011) 0.84
Back pain in seniors: the Back pain Outcomes using Longitudinal Data (BOLD) cohort baseline data. BMC Musculoskelet Disord (2014) 0.83
Cross-cultural validation of a disease-specific patient-reported outcome measure for systemic lupus erythematosus in Canada. J Rheumatol (2013) 0.83
Assessing the factor structure of a role functioning item bank. Qual Life Res (2010) 0.82
An update on the long-term safety experience of ustekinumab: results from the psoriasis clinical development program with up to four years of follow-up. J Drugs Dermatol (2012) 0.82
Content validation of two SF-36 subscales for use in type 2 diabetes and non-dialysis chronic kidney disease-related anemia. Qual Life Res (2010) 0.82
Compulsive cell phone use and history of motor vehicle crash. J Adolesc Health (2013) 0.82
Mapping MOS Sleep Scale scores to SF-6D utility index. Curr Med Res Opin (2007) 0.82
Health-related quality-of-life findings for the prostate cancer prevention trial. J Natl Cancer Inst (2012) 0.81
Switching to adalimumab for psoriasis patients with a suboptimal response to etanercept, methotrexate, or phototherapy: efficacy and safety results from an open-label study. J Am Acad Dermatol (2011) 0.81
Testing item response theory invariance of the standardized Quality-of-life Disease Impact Scale (QDIS(®)) in acute coronary syndrome patients: differential functioning of items and test. Qual Life Res (2015) 0.81